1
项与 自体肿瘤浸润淋巴细胞(翊寿科技) 相关的临床试验Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Advanced Liver Cancer
Single-arm, open-label, interventional study evaluating adoptive cell therapy (ACT) with autologous tumor-infiltrating lymphocytes (TIL) infusion followed by IL-2 after a non-myeloablative(NMA) lymphodepletion preparative regimen for the treatment of patients with advanced liver cancer.
100 项与 自体肿瘤浸润淋巴细胞(翊寿科技) 相关的临床结果
100 项与 自体肿瘤浸润淋巴细胞(翊寿科技) 相关的转化医学
100 项与 自体肿瘤浸润淋巴细胞(翊寿科技) 相关的专利(医药)
100 项与 自体肿瘤浸润淋巴细胞(翊寿科技) 相关的药物交易